NAVARRIA, A., A. TAMBURELLA, F.A. IANNOTTI, Vincenzo MICALE, G. CAMILLIERI, L. GOZZO, R. VERDE, R. IMPERATORE, G.M. LEGGIO, F. DRAGO and Marzo V. DI. The dual blocker of FAAH/TRPV1 N-arachidonoylserotonin reverses the behavioral despair induced by stress in rats and modulates the HPA-axis. PHARMACOLOGICAL RESEARCH. London: ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD, 2014, vol. 87, September, p. 151-159. ISSN 1043-6618. Available from: https://dx.doi.org/10.1016/j.phrs.2014.04.014.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name The dual blocker of FAAH/TRPV1 N-arachidonoylserotonin reverses the behavioral despair induced by stress in rats and modulates the HPA-axis
Authors NAVARRIA, A. (380 Italy), A. TAMBURELLA (380 Italy), F.A. IANNOTTI (380 Italy), Vincenzo MICALE (380 Italy, guarantor, belonging to the institution), G. CAMILLIERI (380 Italy), L. GOZZO (380 Italy), R. VERDE (380 Italy), R. IMPERATORE (380 Italy), G.M. LEGGIO (380 Italy), F. DRAGO (380 Italy) and Marzo V. DI (380 Italy).
Edition PHARMACOLOGICAL RESEARCH, London, ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD, 2014, 1043-6618.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30104 Pharmacology and pharmacy
Country of publisher United Kingdom of Great Britain and Northern Ireland
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 4.408
RIV identification code RIV/00216224:14740/14:00078064
Organization unit Central European Institute of Technology
Doi http://dx.doi.org/10.1016/j.phrs.2014.04.014
UT WoS 000341474400016
Keywords in English N-Arachidonoylserotonin; HPA-axis; Stress; FAAH; TRPV1
Tags kontrola MP, MP, rivok
Tags International impact, Reviewed
Changed by Changed by: Martina Prášilová, učo 342282. Changed: 8/1/2015 07:24.
Abstract
In recent years, several studies have explored the involvement of the deregulation of the hypothalamus-pituitary-adrenal (HPA) axis in the pathophysiology of stress-related disorders. HPA hyper-activation as a consequence of acute/chronic stress has been found to play a major role in the neurobiological changes that are responsible for the onset of such states. Currently available medications for depression, one of the most relevant stress-related disorders, present several limitations, including a time lag for treatment response and low rates of efficacy. N-Arachidonoylserotonin (AA-5-HT), a dual blocker at fatty acid amide hydrolase (FAAH, the enzyme responsible for the inactivation of the endocannabinoid anandamide) and transient receptor potential vanilloid type-1 channel (TRPV1), produces anxiolytic-like effects in mice. The present study was designed to assess the capability of AA-5-HT to reverse the behavioral despair following exposure to stress in rats and the role of the HPA-axis. Behavioral tasks were performed, and corticosterone and endocannabinoid (anandamide and 2-arachidonoylglycerol) levels were measured in selected brain areas critically involved in the pathophysiology of stress-related disorders (medial PFC and hippocampus) under basal and stress conditions, and in response to treatment with AA-5-FIT. Our data show that AA-5-HT reverses the rat behavioral despair in the forced swim test under stress conditions, and this effect is associated with the normalization of the HPA-axis deregulation that follows stress application and only in part with elevation of anandamide levels. Blockade of FAAH and TRPV1 may thus represent a novel target to design novel therapeutic strategies for the treatment of stress-related disorders. (C) 2014 Elsevier Ltd. All rights reserved.
Links
ED1.1.00/02.0068, research and development projectName: CEITEC - central european institute of technology
PrintDisplayed: 27/4/2024 07:07